Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice
- 1 November 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 281 (5) , H1938-H1945
- https://doi.org/10.1152/ajpheart.2001.281.5.h1938
Abstract
Anesthetic regimens commonly administered during studies that assess cardiac structure and function in mice are xylazine-ketamine (XK) and avertin (AV). While it is known that XK anesthesia produces more bradycardia in the mouse, the effects of XK and AV on cardiac function have not been compared. We anesthetized normal adult male Swiss Webster mice with XK or AV. Transthoracic echocardiography and closed-chest cardiac catheterization were performed to assess heart rate (HR), left ventricular (LV) dimensions at end diastole and end systole (LVDd and LVDs, respectively), fractional shortening (FS), LV end-diastolic pressure (LVEDP), the time constant of isovolumic relaxation (τ), and the first derivatives of LV pressure rise and fall (dP/dtmax and dP/dtmin, respectively). During echocardiography, HR was lower in XK than AV mice (250 ± 14 beats/min in XK vs. 453 ± 24 beats/min in AV,P < 0.05). Preload was increased in XK mice (LVDd: 4.1 ± 0.08 mm in XK vs. 3.8 ± 0.09 mm in AV,P < 0.05). FS, a load-dependent index of systolic function, was increased in XK mice (45 ± 1.2% in XK vs. 40 ± 0.8% in AV, P < 0.05). At LV catheterization, the difference in HR with AV (453 ± 24 beats/min) and XK (342 ± 30 beats/min, P < 0.05) anesthesia was more variable, and no significant differences in systolic or diastolic function were seen in the group as a whole. However, in XK mice with HR 300 beats/min, P < 0.05), whereas systolic (LV dP/dtmax: 4,402 ± 798 vs. 8,250 ± 415 mmHg/s in mice with HR >300 beats/min,P < 0.05) and diastolic (τ: 23 ± 2 vs. 14 ± 1 ms in mice with HR >300 beats/min, P < 0.05) function were impaired. Compared with AV, XK produces profound bradycardia with effects on loading conditions and ventricular function. The disparate findings at echocardiography and LV catheterization underscore the importance of comprehensive assessment of LV function in the mouse.Keywords
This publication has 27 references indexed in Scilit:
- Evidence for angiotensin II type 2 receptor–mediated cardiac myocyte enlargement during in vivo pressure overloadJournal of Clinical Investigation, 2000
- Murine Cardiac FunctionCirculation Research, 1998
- End-systolic Pressure–Dimension Relationship ofin situMouse Left VentricleJournal of Molecular and Cellular Cardiology, 1998
- Transthoracic Echocardiography in Models of Cardiac Disease in the MouseCirculation, 1996
- Validation of in vivo two-dimensional echocardiographic dimension measurements using myocardial mass estimates in dogsAmerican Heart Journal, 1987
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsPublished by Elsevier ,1986
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Standardization of M-mode echocardiographic left ventricular anatomic measurementsJournal of the American College of Cardiology, 1984
- A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate)Zeitschrift für Die Gesamte Experimentelle Medizin, 1984
- Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.Journal of Clinical Investigation, 1976